World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 26 April 2021
Main ID:  ISRCTN02622179
Date of registration: 23/09/2014
Prospective Registration: Yes
Primary sponsor: Durham University (UK)
Public title: Can improved housing provide additional protection against clinical malaria over current best practice?
Scientific title: Can improved housing provide additional protection against clinical malaria over current best practice? A household-randomised controlled study
Date of first enrolment: 01/01/2015
Target sample size: 800
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN02622179
Study type:  Interventional
Study design:  Two-armed household clustered-randomised controlled study (Prevention)  
Phase:  Not Applicable
Countries of recruitment
Gambia
Contacts
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Name: Steve    Lindsay
Address:  School of Biological and Biomedical Sciences Durham University Science Laboratories South Road DH1 3LE Durham United Kingdom
Telephone: +44 (0)191 334 1291
Email: S.W.Lindsay@durham.ac.uk
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria:
Houses must meet the following criteria to be selected:
1. Thatched roofs
2. Intact walls (no cracks)
3. Be single-storey square buildings
4. Open eaves
5. No more than four rooms
6. No ceiling (which is equivalent to closed eaves)
7. No screening
8. At least two resident children aged six months to 13 years old (needed in case the study child leaves the study)

Children must be:
1. Aged 6 months to 13 years old
2. Resident in houses enrolled in the study
3. Whose parents/carers give written, informed consent for their child to be included in the study

Assent will also be sought from eligible children >11 years old after the purpose of the study and what is required has been explained to them according to their capability. In the case of school-age children, only those who live in their village during term-time will be eligible for enrolment. In order for the results from this study to be as generalizable as possible, no distinctions will be made in terms of medical condition or physical health.

Exclusion criteria:
1. Children for whom informed consent is not or cannot be provided
2. Children aged under 6 months or over 13 years on 1st June for the year of survey
3. Children expected to be non-residence during several month of the transmission season


Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Malaria
Infections and Infestations
Intervention(s)
All study houses will be provided with a sufficient number of LLINs to be able to cover all sleeping places and we will follow national guidelines to encourage their correct use as this is the current best practice at the beginning of the study. In the intervention arm, representing modern housing, we propose to modify existing thatched roof houses so that they will have metal roofs, closed eaves, screened-air bricks, and screening on the doors and windows (n=400) and the control arm, representing traditional houses, will be left with thatched roofs and open eaves (n=400) until the end of the study.
Primary Outcome(s)
To assess whether improved housing reduces the burden of clinical malaria where coverage of LLINs is high. Incidence of clinical malaria determined by active case detection (ACD) and defined as body (axillary) temperature of =37.5oC, together with the presence of Plasmodium falciparum parasites detected by microscopy. Incidence will be measured from June to December in 2015 and 2016.
Secondary Outcome(s)

1. To determine whether improved housing reduces the rate of parasite infection, parasite density and anaemia in children. Prevalence of malaria infection, splenomegaly and anaemia determined by cross-sectional surveys at the beginning (June) and end of each rainy season (November /December) in 2015 and 2016. The presence of malaria parasites will be determined by microscopy, the presence of an enlarged spleen by palpation and anaemia quantified by measuring haemoglobin using a HemoCue.
2. To find out whether improved housing is associated with a rise in respiratory infections. Measure cough and either a respiratory rate of above the age specific cut-off or chest indrawing during twice weekly visits from June to December in 2015 and 2016.
3. To assess whether improved housing reduces vector density inside houses when compared with LLIN alone. Mean number of female Anopheles gambiae s.l./light trap/night. Estimated entomological inoculation rate (EIR) in each study arm (i.e. mean number of sporozoite infective bites/child/season) from June to December in 2015 and 2016. Collections will be made indoors using CDC light traps and the presence of vectors with sporozoites determined using an ELISA.
4. To determine whether improved housing is acceptable to the residents and sufficiently durable
5. To find out whether these interventions are cost effective
6. To develop a strategy for potential scale-up of improved housing
Secondary ID(s)
Version 0.1
Source(s) of Monetary Support
Global Health Trials (MRC-DfID-Wellcome Trust). MR/M007383/1 (UK)
Secondary Sponsor(s)
Ethics review
Status:
Approval date:
Contact:
1. The Gambia Government/MRC Joint Ethics Committee, 29/10/2014, SCC 1390v3 2. Durham University School of Biological and Biomedical Sciences Ethics Committee, 01/12/2014, Ref: SBBS/EC/1401/RooPfs 12 09 14
Results
Results available: Yes
Date Posted:
Date Completed: 01/02/2017
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history